id | C00000947 |
---|---|
Name | D-Catechol / D-Catechin / Teafuran 30A / (+)-Catechin / Dexcyanidanol / (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol |
CAS RN | 154-23-4 |
Standard InChI | InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2 |
Phytochemical cluster | No. 14 |
---|---|
KCF-S cluster | No. 52 |
By standard InChI | CHEMBL311498 |
---|---|
By standard InChI Main Layer | CHEMBL80941 CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
By LinkDB | C06562 |
---|
By CAS RN | D002392 |
---|
class name | count |
---|---|
rosids | 86 |
asterids | 7 |
eudicotyledons | 5 |
Magnoliophyta | 5 |
Spermatophyta | 5 |
Liliopsida | 4 |
family name | count |
---|---|
Fabaceae | 59 |
Rosaceae | 6 |
Pinaceae | 4 |
Arecaceae | 3 |
Malvaceae | 3 |
Lauraceae | 3 |
Ericaceae | 2 |
Annonaceae | 2 |
Polygonaceae | 2 |
Betulaceae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL583912 |
CHEMBL1741321
(3)
|
1 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | CHEMBL311498 |
CHEMBL1908082
(1)
|
3 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | CHEMBL311498 |
CHEMBL980220
(1)
|
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL311498 |
CHEMBL1613842
(1)
|
4 / 2 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL583912 |
CHEMBL1738312
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL583912 |
CHEMBL1020816
(1)
CHEMBL995707
(4)
CHEMBL1008495 (1) |
0 / 3 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | CHEMBL206452 CHEMBL583912 |
CHEMBL1032505
(2)
|
3 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL311498 |
CHEMBL1614079
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL583912 |
CHEMBL1614076
(1)
|
1 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | CHEMBL206452 |
CHEMBL1227478
(1)
|
0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | CHEMBL206452 |
CHEMBL1227477
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL206452 |
CHEMBL1227480
(1)
|
0 / 0 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | CHEMBL200715 CHEMBL583912 |
CHEMBL921930
(2)
|
0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | CHEMBL206452 |
CHEMBL1227626
(1)
|
0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | CHEMBL206452 |
CHEMBL1799589
(1)
|
0 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL583912 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL311498 CHEMBL583912 |
CHEMBL822904
(1)
CHEMBL1023248
(2)
|
1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL206452 |
CHEMBL1227474
(1)
|
1 / 2 |
P02768 | Serum albumin | Secreted protein | CHEMBL583912 |
CHEMBL1177441
(1)
|
0 / 0 |
P49327 | Fatty acid synthase | Transferase | CHEMBL129482 CHEMBL583912 |
CHEMBL862461
(1)
CHEMBL862462
(1)
CHEMBL1260143 (1) |
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL583912 |
CHEMBL1741325
(3)
|
0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL311498 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL311498 |
CHEMBL1014691
(1)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL206452 |
CHEMBL1794311
(1)
|
2 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL311498 |
CHEMBL1020815
(1)
CHEMBL1008496
(1)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL311498 CHEMBL129482 CHEMBL200715 |
CHEMBL926465
(3)
|
0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | CHEMBL206452 |
CHEMBL1227479
(1)
|
0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL200715 |
CHEMBL1100507
(1)
|
0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | CHEMBL206452 |
CHEMBL1227627
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL311498 CHEMBL206452 |
CHEMBL1614458
(2)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL206452 |
CHEMBL1227625
(1)
|
1 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL311498 |
CHEMBL1613922
(1)
CHEMBL1794486
(1)
|
0 / 0 |
P07998 | Ribonuclease pancreatic | Enzyme | CHEMBL206452 CHEMBL583912 |
CHEMBL1225513
(2)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL583912 |
CHEMBL1794584
(1)
|
2 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL311498 CHEMBL129482 CHEMBL200715 |
CHEMBL926467
(3)
|
0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL206452 |
CHEMBL1227473
(1)
|
0 / 0 |
P07711 | Cathepsin L1 | C1A | CHEMBL583912 |
CHEMBL1614088
(1)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL311498 |
CHEMBL1794569
(1)
|
1 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | CHEMBL583912 |
CHEMBL1738315
(1)
|
0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | CHEMBL583912 |
CHEMBL1738602
(1)
|
3 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL206452 |
CHEMBL1794467
(1)
|
0 / 0 |
P00734 | Prothrombin | S1A | CHEMBL311498 |
CHEMBL976587
(1)
|
4 / 2 |
P04745 | Alpha-amylase 1 | Enzyme | CHEMBL206452 CHEMBL583912 |
CHEMBL964479
(4)
|
0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL200715 CHEMBL583912 |
CHEMBL1056839
(2)
|
2 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL206452 |
CHEMBL1614521
(1)
|
0 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | CHEMBL583912 |
CHEMBL1738514
(1)
|
0 / 1 |
P56817 | Beta-secretase 1 | A1A | CHEMBL129482 |
CHEMBL653507
(2)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL583912 |
CHEMBL1741322
(3)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL206452 |
CHEMBL1228226
(1)
|
0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL311498 CHEMBL583912 |
CHEMBL1614227
(3)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL206452 |
CHEMBL1614038
(1)
|
2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL311498 |
CHEMBL1614171
(1)
|
5 / 2 |
P00374 | Dihydrofolate reductase | Oxidoreductase | CHEMBL583912 |
CHEMBL930269
(1)
|
1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL311498 CHEMBL129482 CHEMBL200715 |
CHEMBL926466
(3)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL583912 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL206452 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL583912 |
CHEMBL1741323
(3)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL583912 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (3) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL311498 CHEMBL583912 |
CHEMBL1794483
(2)
|
0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL311498 |
CHEMBL1614052
(1)
|
1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL311498 CHEMBL206452 CHEMBL583912 |
CHEMBL1614283
(1)
CHEMBL1614466
(1)
CHEMBL1614211 (5) |
0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | CHEMBL206452 |
CHEMBL1908080
(1)
|
5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL311498 CHEMBL206452 |
CHEMBL1614250
(2)
CHEMBL1614421
(2)
CHEMBL1614502 (2) |
4 / 3 |
P07451 | Carbonic anhydrase 3 | Lyase | CHEMBL206452 |
CHEMBL1227475
(1)
|
0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | CHEMBL206452 |
CHEMBL1227476
(1)
|
1 / 1 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | CHEMBL206452 CHEMBL583912 |
CHEMBL937576
(2)
|
0 / 7 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL311498 CHEMBL206452 CHEMBL583912 |
CHEMBL1794536
(5)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL311498 CHEMBL206452 CHEMBL583912 |
CHEMBL1613914
(5)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL311498 CHEMBL206452 |
CHEMBL1613829
(2)
CHEMBL1613928
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL311498 CHEMBL583912 |
CHEMBL1738442
(4)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL206452 |
CHEMBL1614364
(1)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL206452 CHEMBL583912 |
CHEMBL1614257
(2)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL206452 CHEMBL583912 |
CHEMBL1614257
(2)
|
1 / 3 |
Q05513 | Protein kinase C zeta type | Iota | CHEMBL80941 |
CHEMBL769344
(1)
|
0 / 0 |
Q04759 | Protein kinase C theta type | Delta | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
Q05655 | Protein kinase C delta type | Delta | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
1 / 1 |
P05771 | Protein kinase C beta type | Alpha | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
P24723 | Protein kinase C eta type | Eta | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
1 / 0 |
P41743 | Protein kinase C iota type | Iota | CHEMBL80941 |
CHEMBL769344
(1)
|
0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | CHEMBL80941 |
CHEMBL769344
(1)
CHEMBL768505
(1)
|
0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | CHEMBL583912 |
CHEMBL2114881
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D002392 | 9429 |
ABCG2
ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR1 UAQTL1 |
ATP-binding cassette, sub-family G (WHITE), member 2 | Catechin results in decreased expression of ABCG2 protein |
decreases expression
|
protein |
17077187
|
D002392 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Catechin analog results in decreased phosphorylation of AKT1 protein |
decreases phosphorylation
|
protein |
16413414
|
D002392 | 302 |
ANXA2
ANX2 ANX2L4 CAL1H LIP2 LPC2 LPC2D P36 PAP-IV |
annexin A2 | Catechin results in increased expression of ANXA2 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 393 |
ARHGAP4
C1 RGC1 RhoGAP4 SrGAP4 p115 |
Rho GTPase activating protein 4 | Catechin results in decreased expression of ARHGAP4 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 468 |
ATF4
CREB-2 CREB2 TAXREB67 TXREB |
activating transcription factor 4 | Catechin results in increased expression of ATF4 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 472 |
ATM
AT1 ATA ATC ATD ATDC ATE TEL1 TELO1 |
ataxia telangiectasia mutated (EC:2.7.11.1) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of ATM mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 2683 |
B4GALT1
B4GAL-T1 CDG2D GGTB2 GT1 GTB beta4Gal-T1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of B4GALT1 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 56751 |
BARHL1
|
BarH-like homeobox 1 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BARHL1 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BAX mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D002392 | 637 |
BID
FP497 |
BH3 interacting domain death agonist | Catechin results in increased cleavage of and results in increased activity of BID protein |
increases activity
/ increases cleavage |
protein |
20206613
|
D002392 | 388962 |
BOLA3
MMDS2 |
bolA family member 3 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of BOLA3 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 79184 |
BRCC3
BRCC36 C6.1A CXorf53 |
BRCA1/BRCA2-containing complex, subunit 3 (EC:3.1.2.15) | Catechin results in decreased expression of BRCC3 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 694 |
BTG1
|
B-cell translocation gene 1, anti-proliferative | Catechin results in increased expression of BTG1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Catechin analog results in increased activity of CASP3 protein |
increases activity
|
protein |
16413414
|
D002392 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Catechin inhibits the reaction [catechol results in increased activity of CASP3 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
D002392 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Catechin results in increased activity of CASP3 protein |
increases activity
|
protein |
20206613
|
D002392 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Catechin inhibits the reaction [catechol results in increased activity of CASP7 protein] |
decreases reaction
/ increases activity |
protein |
20347921
|
D002392 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Catechin results in increased activity of CASP8 protein |
increases activity
|
protein |
20206613
|
D002392 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Catechin results in increased activity of CASP9 protein |
increases activity
|
protein |
20206613
|
D002392 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Catechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | Catechin analog results in decreased expression of CCND1 protein |
decreases expression
|
protein |
16413414
|
D002392 | 930 |
CD19
B4 CVID3 |
CD19 molecule | Catechin results in increased expression of CD19 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 975 |
CD81
CVID6 S5.7 TAPA1 TSPAN28 |
CD81 molecule | Catechin results in increased expression of CD81 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 928 |
CD9
BTCC-1 DRAP-27 MIC3 MRP-1 TSPAN-29 TSPAN29 |
CD9 molecule | Catechin results in increased expression of CD9 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 1054 |
CEBPG
GPE1BP IG/EBP-1 |
CCAAT/enhancer binding protein (C/EBP), gamma | Catechin results in increased expression of CEBPG mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 10978 |
CLP1
HEAB hClp1 |
cleavage and polyadenylation factor I subunit 1 (EC:2.7.1.78) | Catechin results in decreased expression of CLP1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 10063 |
COX17
|
COX17 cytochrome c oxidase copper chaperone | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of COX17 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 3627 |
CXCL10
C7 IFI10 INP10 IP-10 SCYB10 crg-2 gIP-10 mob-1 |
chemokine (C-X-C motif) ligand 10 | Catechin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Catechin affects the localization of CYCS protein |
affects localization
|
protein |
20206613
|
D002392 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Catechin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
14558788
|
D002392 | 7913 |
DEK
D6S231E |
DEK oncogene | Catechin results in decreased expression of DEK mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 1786 |
DNMT1
ADCADN AIM CXXC9 DNMT HSN1E MCMT |
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | Catechin results in decreased activity of DNMT1 protein |
decreases activity
|
protein |
16037419
|
D002392 | 2130 |
EWSR1
EWS bK984G1.4 |
EWS RNA-binding protein 1 | Catechin results in increased expression of EWSR1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 355 |
FAS
ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Fas cell surface death receptor | Catechin results in increased expression of FAS protein |
increases expression
|
protein |
20206613
|
D002392 | 2323 |
FLT3LG
FL FLT3L |
fms-related tyrosine kinase 3 ligand | Catechin results in decreased expression of FLT3LG mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 2495 |
FTH1
FHC FTH FTHL6 PIG15 PLIF |
ferritin, heavy polypeptide 1 (EC:1.16.3.1) | Catechin results in increased expression of FTH1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 2896 |
GRN
CLN11 GEP GP88 PCDGF PEPI PGRN |
granulin | Catechin results in increased expression of GRN mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21882252
|
D002392 | 3054 |
HCFC1
CFF HCF-1 HCF1 HFC1 MRX3 VCAF |
host cell factor C1 (VP16-accessory protein) | Catechin results in increased expression of HCFC1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | Catechin results in increased expression of HMOX1 protein |
increases expression
|
protein |
16799064
|
D002392 | 3232 |
HOXD3
HOX1D HOX4 HOX4A Hox-4.1 |
homeobox D3 | Catechin results in increased expression of HOXD3 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3329 |
HSPD1
CPN60 GROEL HLD4 HSP-60 HSP60 HSP65 HuCHA60 SPG13 |
heat shock 60kDa protein 1 (chaperonin) | Catechin results in decreased expression of HSPD1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | Catechin results in increased expression of ICAM1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3586 |
IL10
CSIF GVHDS IL-10 IL10A TGIF |
interleukin 10 | Catechin results in increased expression of IL10 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Catechin inhibits the reaction [Glucose results in increased expression of IL1B mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D002392 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Catechin inhibits the reaction [Glucose results in increased expression of IL1B protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D002392 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Catechin inhibits the reaction [S100B protein results in increased expression of IL1B mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 3559 |
IL2RA
CD25 IDDM10 IL2R TCGFR |
interleukin 2 receptor, alpha | Catechin results in decreased expression of IL2RA mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 9235 |
IL32
IL-32alpha IL-32beta IL-32delta IL-32gamma NK4 TAIF TAIFa TAIFb TAIFc TAIFd |
interleukin 32 | Catechin results in decreased expression of IL32 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 3662 |
IRF4
LSIRF MUM1 NF-EM5 |
interferon regulatory factor 4 | Catechin results in decreased expression of IRF4 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 3683 |
ITGAL
CD11A LFA-1 LFA1A |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | Catechin results in increased expression of ITGAL mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 3689 |
ITGB2
CD18 LAD LCAMB LFA-1 MAC-1 MF17 MFI7 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | Catechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 4067 |
LYN
JTK8 p53Lyn p56Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) | Catechin results in decreased expression of LYN mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21882252
|
D002392 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | Catechin results in decreased expression of MAP2K1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | Catechin results in decreased expression of MAP2K1 protein |
decreases expression
|
protein |
15465739
|
D002392 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | Catechin results in increased expression of MAP2K1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 5605 |
MAP2K2
CFC4 MAPKK2 MEK2 MKK2 PRKMK2 |
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAP2K2 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21882252
|
D002392 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Catechin analog results in decreased phosphorylation of MAPK1 protein |
decreases phosphorylation
|
protein |
16413414
|
D002392 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21882252
|
D002392 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D002392 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Catechin results in increased phosphorylation of MAPK1 protein |
increases phosphorylation
|
protein |
17379280
|
D002392 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Catechin analog results in decreased phosphorylation of MAPK3 protein |
decreases phosphorylation
|
protein |
16413414
|
D002392 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of MAPK3 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21882252
|
D002392 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Catechin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D002392 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Catechin results in increased phosphorylation of MAPK3 protein |
increases phosphorylation
|
protein |
17379280
|
D002392 | 4282 |
MIF
GIF GLIF MMIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) | Catechin results in decreased expression of MIF mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 64975 |
MRPL41
BMRP MRP-L27 MRPL27 RPML27 |
mitochondrial ribosomal protein L41 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MRPL41 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 4493 |
MT1E
MT1 MTD |
metallothionein 1E | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of MT1E mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 653361 |
NCF1
NCF1A NOXO2 SH3PXD1A p47phox |
neutrophil cytosolic factor 1 | Catechin inhibits the reaction [S100B protein results in increased expression of NCF1 protein] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 653361 |
NCF1
NCF1A NOXO2 SH3PXD1A p47phox |
neutrophil cytosolic factor 1 | Catechin results in decreased expression of NCF1 mRNA |
decreases expression
|
mRNA |
19450372
|
D002392 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | Catechin results in increased expression of NFE2L2 protein |
increases expression
|
protein |
16799064
|
D002392 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D002392 | 4851 |
NOTCH1
TAN1 hN1 |
notch 1 | Catechin results in increased expression of NOTCH1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 4869 |
NPM1
B23 NPM |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Catechin results in decreased expression of NPM1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 5175 |
PECAM1
CD31 CD31/EndoCAM GPIIA' PECA1 PECAM-1 endoCAM |
platelet/endothelial cell adhesion molecule 1 | Catechin inhibits the reaction [S100B protein results in increased expression of PECAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 5187 |
PER1
PER RIGUI hPER |
period circadian clock 1 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of PER1 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 5327 |
PLAT
T-PA TPA |
plasminogen activator, tissue (EC:3.4.21.68) | Catechin results in increased expression of PLAT mRNA |
increases expression
|
mRNA |
11236827
|
D002392 | 5327 |
PLAT
T-PA TPA |
plasminogen activator, tissue (EC:3.4.21.68) | Catechin results in increased expression of PLAT protein |
increases expression
|
protein |
11236827
|
D002392 | 5327 |
PLAT
T-PA TPA |
plasminogen activator, tissue (EC:3.4.21.68) | Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAT mRNA] |
decreases reaction
/ increases expression |
mRNA |
11236827
|
D002392 | 5328 |
PLAU
ATF BDPLT5 QPD UPA URK u-PA |
plasminogen activator, urokinase (EC:3.4.21.73) | Catechin results in increased expression of PLAU mRNA |
increases expression
|
mRNA |
11236827
|
D002392 | 5328 |
PLAU
ATF BDPLT5 QPD UPA URK u-PA |
plasminogen activator, urokinase (EC:3.4.21.73) | Catechin results in increased expression of PLAU protein |
increases expression
|
protein |
11236827
|
D002392 | 5328 |
PLAU
ATF BDPLT5 QPD UPA URK u-PA |
plasminogen activator, urokinase (EC:3.4.21.73) | Dactinomycin inhibits the reaction [Catechin results in increased expression of PLAU mRNA] |
decreases reaction
/ increases expression |
mRNA |
11236827
|
D002392 | 7916 |
PRRC2A
BAT2 D6S51 D6S51E G2 |
proline-rich coiled-coil 2A | Catechin results in increased expression of PRRC2A mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D002392 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D002392 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Catechin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Catechin results in decreased expression of PTGS2 mRNA |
decreases expression
|
mRNA |
10920275
|
D002392 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Catechin results in increased phosphorylation of PTK2 protein |
increases phosphorylation
|
protein |
16038899
|
D002392 | 5879 |
RAC1
Rac-1 TC-25 p21-Rac1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | Catechin results in decreased expression of RAC1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 5915 |
RARB
HAP NR1B2 RRB2 |
retinoic acid receptor, beta | Catechin results in decreased metabolism of RARB promoter |
decreases metabolic processing
|
promoter |
16037419
|
D002392 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Catechin inhibits the reaction [Glucose affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
19557821
|
D002392 | 6128 |
RPL6
L6 SHUJUN-2 TAXREB107 TXREB1 |
ribosomal protein L6 | Catechin results in increased expression of RPL6 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased abundance of Reactive Oxygen Species] |
decreases reaction
/ increases abundance |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of IL1B mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of NCF1 protein] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of PECAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6285 |
S100B
NEF S100 S100-B S100beta |
S100 calcium binding protein B | Catechin inhibits the reaction [S100B protein results in increased expression of TNF mRNA] |
decreases reaction
/ increases expression |
protein |
17103373
|
D002392 | 6286 |
S100P
MIG9 |
S100 calcium binding protein P | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Catechin results in decreased expression of SERPINE1 mRNA] |
decreases expression
/ decreases reaction |
mRNA |
17379280
|
D002392 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Catechin results in decreased expression of SERPINE1 mRNA |
decreases expression
|
mRNA |
17379280
|
D002392 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | U 0126 inhibits the reaction [Catechin results in decreased expression of SERPINE1 mRNA] |
decreases expression
/ decreases reaction |
mRNA |
17379280
|
D002392 | 7536 |
SF1
BBP D11S636 MBBP ZCCHC25 ZFM1 ZNF162 |
splicing factor 1 | Catechin results in decreased expression of SF1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 6574 |
SLC20A1
GLVR1 Glvr-1 PIT1 PiT-1 |
solute carrier family 20 (phosphate transporter), member 1 | Catechin results in increased expression of SLC20A1 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 6699 |
SPRR1B
CORNIFIN GADD33 SPRR1 |
small proline-rich protein 1B | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of SPRR1B mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
21882252
|
D002392 | 6772 |
STAT1
CANDF7 ISGF-3 STAT91 |
signal transducer and activator of transcription 1, 91kDa | Catechin results in decreased expression of STAT1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 6772 |
STAT1
CANDF7 ISGF-3 STAT91 |
signal transducer and activator of transcription 1, 91kDa | Catechin results in decreased expression of STAT1 protein |
decreases expression
|
protein |
15465739
|
D002392 | 6777 |
STAT5B
STAT5 |
signal transducer and activator of transcription 5B | Catechin results in increased expression of STAT5B mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 6778 |
STAT6
D12S1644 IL-4-STAT STAT6B STAT6C |
signal transducer and activator of transcription 6, interleukin-4 induced | Catechin results in increased expression of STAT6 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 6817 |
SULT1A1
HAST1/HAST2 P-PST PST ST1A1 ST1A3 STP STP1 TSPST1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | SULT1A1 protein SNP results in increased sulfation of Catechin |
increases sulfation
|
protein |
17293380
|
D002392 | 6932 |
TCF7
TCF-1 |
transcription factor 7 (T-cell specific, HMG-box) | Catechin results in increased expression of TCF7 mRNA |
increases expression
|
mRNA |
15465739
|
D002392 | 7083 |
TK1
TK2 |
thymidine kinase 1, soluble (EC:2.7.1.21) | Catechin results in decreased expression of TK1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Catechin inhibits the reaction [Glucose results in increased expression of TNF mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D002392 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Catechin inhibits the reaction [Glucose results in increased expression of TNF protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D002392 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Catechin inhibits the reaction [S100B protein results in increased expression of TNF mRNA] |
decreases reaction
/ increases expression |
mRNA |
17103373
|
D002392 | 943 |
TNFRSF8
CD30 D1S166E Ki-1 |
tumor necrosis factor receptor superfamily, member 8 | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in decreased expression of TNFRSF8 mRNA] |
affects cotreatment
/ decreases expression / decreases reaction |
mRNA |
21882252
|
D002392 | 943 |
TNFRSF8
CD30 D1S166E Ki-1 |
tumor necrosis factor receptor superfamily, member 8 | Catechin results in decreased expression of TNFRSF8 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 7150 |
TOP1
TOPI |
topoisomerase (DNA) I (EC:5.99.1.2) | Catechin results in decreased expression of TOP1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 7150 |
TOP1
TOPI |
topoisomerase (DNA) I (EC:5.99.1.2) | Catechin results in decreased expression of TOP1 protein |
decreases expression
|
protein |
15465739
|
D002392 | 7153 |
TOP2A
TOP2 TP2A |
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | Catechin results in decreased expression of TOP2A mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 2829 |
XCR1
CCXCR1 GPR5 |
chemokine (C motif) receptor 1 | Catechin results in decreased expression of XCR1 mRNA |
decreases expression
|
mRNA |
15465739
|
D002392 | 51042 |
ZNF593
ZT86 |
zinc finger protein 593 | Catechin results in increased expression of ZNF593 mRNA |
increases expression
|
mRNA |
15465739
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#114550 | Hepatocellular carcinoma |
P08581
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P08581 (related) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00018 | Gastric cancer |
P08581
(related)
P10415 (related) |
H00046 | Cholangiocarcinoma |
P08581
(related)
P35354 (related) |
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P10415
(related)
P28907 (marker) |
H00013 | Small cell lung cancer |
P10415
(related)
|
H00028 | Choriocarcinoma |
P10415
(related)
|
H00030 | Cervical cancer |
P10415
(related)
|
H00041 | Kaposi's sarcoma |
P10415
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q01453
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D050197 | D002392 | Atherosclerosis |
therapeutic
|
16806235
|
|
D001943 | D002392 | Breast Neoplasms |
therapeutic
|
23061908
|
|
D002471 | D002392 | Cell Transformation, Neoplastic |
therapeutic
|
21882252
|
|
D003556 | D002392 | Cystitis |
therapeutic
|
15800758
|
|
D056486 | D002392 | Drug-Induced Liver Injury |
therapeutic
|
20211157
|
|
D034381 | D002392 | Hearing Loss |
therapeutic
|
20883750
|
|
D006331 | D002392 | Heart Diseases |
therapeutic
|
8564920
|
|
D020138 | D002392 | HYPERHOMOCYSTEINEMIA |
therapeutic
|
17292331
|
|
D008107 | D002392 | Liver Diseases |
therapeutic
|
19428341
|
|
D017114 | D002392 | Liver Failure, Acute |
therapeutic
|
1874459
|
|
D008113 | D002392 | Liver Neoplasms |
therapeutic
|
8603484
|
|
D008325 | D002392 | Mammary Neoplasms, Experimental |
therapeutic
|
11962253
|
|
D009362 | D002392 | Neoplasm Metastasis |
therapeutic
|
23061908
|